TBX-501

N/A

Report date: 2025/05/08 10:52:48

Base Information

Drug NameTBX-501
Drug Alias NameTBX-501
ClassificationBiologics
Mechanisms of ActionInterleukin-2 stimulantsMicrobiome modulators
TargetsInterleukin-2
Therapy Area/IndicationsRectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTrobix Bio
China Registration ClassN/A

Develop Information

Active CompaniesTrobix Bio
Inactive CompaniesN/A
Active IndicationsRectal Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A